Prognostic significance ofp53 mutation in breast cancer: Frequent detection of non-missense mutations by yeast functional assay
- 22 December 1999
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 84 (6), 587-593
- https://doi.org/10.1002/(sici)1097-0215(19991222)84:6<587::aid-ijc8>3.0.co;2-8
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Identification of human p53 mutations with differential effects on the bax and p21 promoters using functional assays in yeastOncogene, 1998
- IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation toolsNucleic Acids Research, 1998
- Absence of p21 expression is associated with abnormal p53 in human breast carcinomasBritish Journal of Cancer, 1997
- The molecular epidemiology of P53 gene mutations in human breast cancerTrends in Genetics, 1997
- Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value.Proceedings of the National Academy of Sciences, 1996
- The prognostic value of DNA ploidy and S—phase estimate in primary breast cancer: A prospective studyInternational Journal of Cancer, 1995
- A simple p53 functional assay for screening cell lines, blood, and tumors.Proceedings of the National Academy of Sciences, 1995
- Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic indexCancer, 1991
- A Randomized Clinical Trial Evaluating Sequential Methotrexate and Fluorouracil in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor-Negative TumorsNew England Journal of Medicine, 1989
- The correlation of growth fractions with histologic grading and lymph node status in human mammary carcinomaCancer, 1987